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Abstract
Fifty-one children (median age: 4.5 years; 4 months-16 years) diagnosed with rhabdomyosar-
coma were treated in our center between 1980-1999. The primary sites were head and neck
in 31.4%, the genito-urinary system in 21.6%, and extremities in 9.8% of the patients. The
histopathologic subtypes were embryonal in 80.4%, alveolar in 9.8%, and undifferentiated in
9.8%. The majority of the patients were considered group III (47%) and group IV (25.5%) accord-
ing the criteria of the Intergroup Rhabdomyosarcoma Study (IRS). Primary total tumour resection
was performed in only 27.5% of the patients. The patients were treated with assigned regimens
of IRS II and IRS III protocols. Radiotherapy was applied to 92.1% of the patients. Thirty-four
patients (66.7%) were lost to follow up, and of the remaining 17 patients, 7 patients (41.2%) died,
relapse occurred in 9 patients (52.9%) and 10 patients (58.8%) are alive. The percentage of cases
lost to follow up during the first 10 years and the following 9 years of the study were 77.4% and
50%, respectively. In compliance with cancer treatment remains a major problem in developing
countries.
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